Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-06-24

Clinical Trial Update: Can Rivaroxaban Lead to Anticoagulation-Related Nephropathy?

View source ↗

Summary

A completed clinical trial exploring whether rivaroxaban contributes to anticoagulation-related nephropathy in patients with acute kidney injury; results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rivaroxaban (rivaroxaban)

Snippet

Sponsor: Albert Einstein Healthcare Network | Conditions: Acute Kidney Injury | Status: COMPLETED | Results posted: 2020-06-24